SEARCH BY
| Category | Company |
|---|---|
| Founded | 1849 |
| Sector | Life Science |
| Employees | 81,000 |
| Revenue | 63.6B USD (2024) |
Pfizer is a global pharmaceutical company that is involved in the discovery, development, manufacture, and marketing of a wide range of healthcare products, including medicines and vaccines. The company's portfolio includes treatments across a broad spectrum of areas such as oncology, cardiology, neurology, and infectious diseases, among others. Pfizer was founded in 1849 and is based in New York, New York.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 46 |
| Sector: Life Science M&A | 2 of 41 |
| Type: Add-on Acquisition M&A Deals | 1 of 33 |
| State: New Jersey M&A | 2 of 3 |
| Country: United States M&A | 2 of 33 |
| Year: 2003 M&A | 1 of 2 |
| Size (of disclosed) | 3 of 24 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2002-12-17 |
Cadbury Adams USA
Parsippany, New Jersey, United States Cadbury Adams is a provider of confectionery products. Adams does business in over 70 countries. |
Sell | $4.2B |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2003-11-25 |
Pfizer s New Drug Application
United States Pfizer's New Drug Application (NDA) for Cardura(R) XL, a sustained-release formulation of doxazosin mesylate, used to treat benign prostatic hyperplasia (BPH). |
Sell | $35M |
